Related Experiment Video
Updated: Jul 3, 2026

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Topical therapy in pediatric atopic dermatitis
Andrew C Krakowski1, Magdalene A Dohil
1University of California, San Diego, CA, USA.
Atopic dermatitis (AD) affects 10-20% of children, presenting a chronic challenge with limited treatments. This review compares topical corticosteroids and calcineurin inhibitors for managing pediatric AD, discussing safety and compliance.
Area of Science:
- Dermatology
- Pediatrics
- Pharmacology
Background:
- Atopic dermatitis (AD) is a prevalent chronic skin condition in children, affecting 10-20% within the first decade of life.
- Current management relies heavily on topical anti-inflammatory agents, necessitating a balance between efficacy and safety, particularly in pediatric patients.
Purpose of the Study:
- To review the principles of topical therapy for atopic dermatitis.
- To compare topical corticosteroids and topical calcineurin inhibitors for AD management.
- To discuss specialized treatment strategies and common compliance challenges in pediatric AD.
Main Methods:
- Literature review of topical anti-inflammatory agents for atopic dermatitis.
- Comparative analysis of topical corticosteroids and topical calcineurin inhibitors.
- Discussion of adjunctive therapies like wet wraps and bleach baths.
Main Results:
- Topical corticosteroids and calcineurin inhibitors represent core therapeutic options for AD.
- Each agent class possesses distinct efficacy and safety profiles relevant to pediatric use.
- Specialized strategies and adherence barriers significantly impact treatment outcomes.
Conclusions:
- Optimizing topical AD therapy requires careful consideration of agent class, patient age, and safety.
- Understanding treatment differences and compliance factors is crucial for effective pediatric AD management.
- Further research may explore novel topical treatments and adherence interventions.
Related Concept Videos
Acne Infection
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
